Development Program Activities. Following completion of each Discovery Program, TESARO shall be responsible, at its sole expense, for conducting the Development Program, which shall include without limitation all pre-IND activities, including cross-reactivity studies and pilot studies to enable GLP pharmacology/toxicology studies, GMP manufacturing, regulatory filings, clinical trials and commercialization activities with respect to one or more Development Antibodies under each Development Program.
Appears in 6 contracts
Samples: Collaboration and Exclusive License Agreement, Collaboration and Exclusive License Agreement (Anaptysbio Inc), Collaboration and Exclusive License Agreement (Anaptysbio Inc)
